Small Molecules Identified from a Quantitative Drug Combinational Screen Resensitize Cisplatin's Response in Drug-Resistant Ovarian Cancer Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Small Molecules Identified from a Quantitative Drug Combinational Screen Resensitize Cisplatin's Response in Drug-Resistant Ovarian Cancer Cells

Published:2018-08 Issue:4 Volume:11 Page:1053-1064
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Sima Ni,Sun Wei,Gorshkov Kirill^ORCID,Shen Min,Huang Wei,Zhu Wenge,Xie Xing,Zheng Wei^ORCID,Cheng Xiaodong

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference64 articles.

1. Optimal first-line treatment in ovarian cancer;Raja;Ann Oncol,2012

2. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

3. Addition of Epirubicin As a Third Drug to Carboplatin-Paclitaxel in First-Line Treatment of Advanced Ovarian Cancer: A Prospectively Randomized Gynecologic Cancer Intergroup Trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens

4. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup;Bookman;J Clin Oncol,2009

5. Molecular mechanisms of cisplatin resistance;Galluzzi;Oncogene,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small-molecule High-throughput Screening Identifies an MEK Inhibitor PD198306 that Enhances Sorafenib Efficacy via MCL-1 and BIM in Hepatocellular Carcinoma Cells;Combinatorial Chemistry & High Throughput Screening;2023-06

2. BRAF Inhibitor Resistance Confers Increased Sensitivity to Mitotic Inhibitors;Frontiers in Oncology;2022-04-04

3. Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib;Biomolecules;2021-07-16

4. BRAF inhibitor resistance confers increased sensitivity to mitotic inhibitors;2021-04-15

5. CENPE Inhibition Leads to Mitotic Catastrophe and DNA Damage in Medulloblastoma Cells;Cancers;2021-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3